41
Patient experience driving real change Ben Page, Chief Executive, Ipsos MORI [email protected]

Patient experience – driving real change - King's Fund · PDF filePatient experience – driving real change Ben Page, Chief ... • Project Expand ... placed them right next to

  • Upload
    lambao

  • View
    216

  • Download
    1

Embed Size (px)

Citation preview

  • Ipsos MORI

    Patient experience driving real changeBen Page, Chief Executive, Ipsos MORI

    [email protected]

  • Ipsos MORI

    The NHS is awash with data

  • Ipsos MORI

    Paste co-brand logo

    here

    44%

    42%

    9% 3%1%

    Very good Fairly good Neither good nor poor Fairly poor Very poor

    Very positive about many aspects of experience

    Base: All patients who answered question (in brackets) Source: Ipsos MORI

    46%

    42%

    8% 3%1%

    December 2013(922,112)

    December 2012(956,509)

    Overall, how would you describe your experience of your GP surgery?

  • Ipsos MORI

    So does this mean that measuring experience is pointless?

  • Ipsos MORI

    Is your GP surgery currently open at times that are convenient for you?

    When there is high satisfaction look at sub groups

    Base: All patients who were able to get an appointment to see or speak to someone and answered question (in brackets) Source: Ipsos MORI

    68 6770 71

    80

    9294

    91

    60

    65

    70

    75

    80

    85

    90

    95

    100

    18 to 24 25 to 34 35 to 44 45 to 54 55 to 64 65 to 74 75 to 84 85 and over

    Yes

    (%)

    Yes (%)

  • Ipsos MORI

    0 1 2 3 4 5 6 7 8 9

    Look at patterns in the data and key drivers of perception

    Q28: Overall, how would you describe your experience of your surgery?

    Experience of making an appointment

    Experience of the GP

    Trust/confidence in GP

    Getting through on phone

    Satisfaction with opening hours

    Experience of the nurse

    Seeing preferred GP

    Drivers of overall experience of GP Surgery

    Helpfulness of receptionists

    Waiting times

    63% of the variance explained by the model

    Rank

    Rel

    ativ

    e im

    porta

    nce

  • Ipsos MORI

    Understand what were measuring

  • Ipsos MORI

    Paste co-brand logo

    hereSometimes an overall measure can mask poor experience

    On third day she asked for a bedpan Nurse told her it wasnt worth running back and forth, told her to do it in the bed Nurse complained to her in the morning that she was soaking wet

    in [the hospital] they treated me well Oh yes I found it satisfactory

    Female, white, 65+, in hospital for several months

    Her report Her experience

  • Ipsos MORI

    Paste co-brand logo

    hereWe know external factors affect results...

  • Ipsos MORI

    Paste co-brand logo

    here

    How do we make better use of this data?

  • Ipsos MORI

    Paste co-brand logo

    hereHow researchers view feedback

    Its research data its about precisely measuring the experience of my patients

    Am I using reliable, robust, validated measures?

    How can I act if I only have data from 10% of patients?

    Have I got a representative sample?

    How are my data collection methods introducing bias?

  • Ipsos MORI

    Paste co-brand logo

    hereBut what managers and service improvers need...

    Its management information to help me identify where theres a problem and prioritise what needs fixing

    Are my measures good enough? Do they have the detail to know what needs fixing?

    10%, wow! If they say its a problem, I at least need to investigate

    Maybe its not representative but better than nothing. Ill go and investigate

    Maybe there is some bias but does it let me compare different wards, and know where to act?

    Its research data its about precisely measuring the experience of my patients

    Am I using reliable, robust, validated measures?

    How can I act if I only have data from 10% of patients?

    Have I got a representative sample?

    How are my data collection methods introducing bias?

  • 13

    HOW MUCH TIMEDO I HAVE?

    ARE YOU STILL PAYING ATTENTION?

  • Title line 1

    14

    Source: Statistic Brain

    A (SHORT) HISTORYOF ATTENTION SPANS

    2000

    12 secs

    Today

    8 secs

    9 secs

  • Version 2 | Internal use only Ipsos MORI

    Think about getting data used

  • Version 2 | Internal use only Ipsos MORI Version 2 | Internal use only Ipsos MORI

    Our reports have a problem, my friend

    Average number of words

    Average number of pages

    Average number of standard charts/tables

  • Version 2 | Internal use only Ipsos MORI

    The Brief

    RESEARCH BRIEF: (filled in by Project Requestor) Background:

    Gaviscon is the number 1 selling heartburn and indigestion remedy in the UK commanding 34% value share of the market, and growing strongly ahead of a relatively flat marketplace at 17.3% YoY. Gaviscon OTC is viewed by consumers and has traditionally been marketed by Reckitt Benckiser as a treatment for moderate to severe indigestion, commonly termed Heartburn. However, the strong growth achieved over the last few years has come by continuing with the strategy of trading up dissatisfied antacid users into the brand from the less efficacious, lower value, higher volume antacid sector. Activities driving this growth through trade-up in the last year have been: Project Expand the launch of a limited range of Gaviscon products into full grocery distribution which

    placed them right next to the antacids that people were buying out of habit, or as the ubiquitous entry point into the category.

    Tablets TV The fire breather creative was developed to make the Gaviscon brand more approachable and less medicinal to antacid users. This was the first time that tablets had been advertised, being the preferred format of the majority of users (65%) and the format that antacid users are used to.

    The results have been very impressive, with growth coming from some switching from the main antacid brands (e.g. Rennie), but also by bringing in many new market buyers resulting in a 20-25% increase in category sales within all of the major multiple grocers.

    This strategy would only work of course if we maintained our core pharmacy business. Thus far we are only down 0.7% YoY in value terms in pharmacy as a result. Therefore, from a sales perspective these moves have been very

    successful. What interests us now is whether our moves, and the introduction of H2s (e.g. Zantac) and H2/antacid combination products (e.g. Pepcidtwo) into full grocery distribution, have influenced brand perceptions or the linear brand progression that has been assumed up until know (antacid alginate H2). In essence do the conceptual targets that we have used over the last couple of years still hold and what size is each group.

  • Version 2 | Internal use only Ipsos MORI

    ISO9000ISO9000

    Project Thistle - US Malt Drinkers Online(10889) - Wave 1 Apr 04 22IpsosIpsos--FocusFocus

    NORMALISED BRAND IMAGE SCORESNORMALISED BRAND IMAGE SCORES

    Do Do Brand A Brand B Brand C Brand D Brand E Brand F Brand G Brand H Brand IBase 197 198 193 193 133 143 75 94 82 64Fashionable 1.55 1.51 0.98 0.99 0.81 0.62 0.71 0.62 0.60 0.58Stylish 1.31 1.00 1.03 1.00 1.05 0.96 0.89 0.74 0.82 0.57Traditional 1.21 1.33 0.94 1.03 0.84 0.95 0.77 0.83 0.68 0.98GVFM 0.97 1.52 1.02 1.03 0.91 0.78 0.82 0.78 0.74 1.14Darker coloured 1.43 2.04 0.62 0.43 0.66 0.76 0.82 1.27 0.93 1.73Seen in all bars 2.18 2.33 0.87 1.04 0.49 0.27 0.06 0.07 0.13 0.32Range of products 0.97 3.32 0.47 0.69 0.99 0.63 0.35 0.28 0.93 0.16Attractive bottle 1.65 0.80 1.11 0.69 0.81 0.82 1.00 0.99 1.01 1.45Serious 0.64 0.60 1.05 1.05 1.08 1.23 1.25 1.33 1.13 1.15Authentic 0.71 0.70 1.02 1.02 1.13 1.17 1.23 1.16 1.19 1.25Proud to serve 0.78 0.73 1.08 1.16 1.09 1.03 0.99 1.05 1.12 1.12Gift 1.03 0.91 1.00 1.00 1.02 1.05 0.98 0.98 1.09 0.92Distinctive taste 0.76 0.67 1.07 0.96 1.02 1.09 1.29 1.34 1.14 1.41Sophisticated 0.76 0.52 1.06 1.06 1.16 1.21 1.22 1.26 1.15 0.78Different 0.55 0.52 1.01 1.01 1.04 1.15 1.54 1.52 1.36 1.29Becoming more popular 0.81 0.99 1.17 1.27 1.14 0.99 0.63 0.74 0.88 0.55Would recommend 0.66 0.61 1.10 1.13 1.21 1.23 1.21 0.93 1.22 0.72High quality 0.82 0.75 1.02 0.99 1.06 1.14 1.14 1.12 1.19 1.34For confident people 0.90 0.78 0.95 1.04 1.07 1.11 1.07 1.18 1.13 1.05For successful people 0.93 0.73 1.03 1.00 1.10 1.11 1.12 1.10 1.08 0.98

    Q5a Please indicate which, if any, of the brands shown here you think each description applies to.

    Key to colours:Positive association - 99% significance levelPositive association - 95% signficance levelNegative association - 95% signficance levelNegative association - 99% significance level

    2 = (oi - ei)2

    eiei = expected frequency

    oi = observed frequency

    Q1

    ISO9000

    Project Thistle - US Malt Drinkers Online(10889) - Wave 1 Apr 04

    *

    Ipsos-Focus

    NORMALISED BRAND IMAGE SCORES

    Do Do

    Brand A

    Brand B

    Brand C

    Brand D

    Brand E

    Brand F

    Brand G

    Brand H

    Brand I

    Base

    197

    198

    193

    193

    133

    143

    75

    94

    82

    64

    Fashionable

    1.55

    1.51

    0.98

    0.99

    0.81

    0.62

    0.71

    0.62

    0.60

    0.58

    Stylish

    1.31

    1.00

    1.03

    1.00

    1.05

    0.96

    0.89

    0.74

    0.82

    0.57

    Traditional

    1.21

    1.33

    0.94

    1.03

    0.84

    0.95

    0.77

    0.83

    0.68

    0.98

    GVFM

    0.97

    1.52

    1.02

    1.03

    0.91

    0.78

    0.82

    0.78

    0.74

    1.14

    Darker coloured

    1.43

    2.04

    0.62

    0.43

    0.66

    0.76

    0.82

    1.27

    0.93

    1.73

    Seen in all bars

    2.18